bibliographic resource 2809539 [br/2809539]
https://w3id.org/oc/corpus/br/2809539

is a

• document
• article

title

• A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

publication date

• 2010-01-01

contributor

• https://w3id.org/oc/corpus/ar/10381348
• https://w3id.org/oc/corpus/ar/10381349
• https://w3id.org/oc/corpus/ar/10381350
• https://w3id.org/oc/corpus/ar/10381351
• https://w3id.org/oc/corpus/ar/10381352
• https://w3id.org/oc/corpus/ar/10381353
• https://w3id.org/oc/corpus/ar/10381354
• https://w3id.org/oc/corpus/ar/10381355
• https://w3id.org/oc/corpus/ar/10381356
• https://w3id.org/oc/corpus/ar/10381357
• https://w3id.org/oc/corpus/ar/10381358
• https://w3id.org/oc/corpus/ar/10381359
• https://w3id.org/oc/corpus/ar/10381360

format

• https://w3id.org/oc/corpus/re/1510808

identifier

• https://w3id.org/oc/corpus/id/5390325
• https://w3id.org/oc/corpus/id/5390326
• https://w3id.org/oc/corpus/id/5390327
• https://w3id.org/oc/corpus/id/5390328

part of

• https://w3id.org/oc/corpus/br/251133